Advisors Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $215K | Sell |
12,544
-3,753
| -23% | -$64.2K | ﹤0.01% | 1110 |
|
2025
Q1 | $1.04M | Buy |
16,297
+4,728
| +41% | +$302K | 0.02% | 737 |
|
2024
Q4 | $1.41M | Sell |
11,569
-3,300
| -22% | -$401K | 0.03% | 649 |
|
2024
Q3 | $1.86M | Buy |
14,869
+43
| +0.3% | +$5.37K | 0.03% | 581 |
|
2024
Q2 | $2.34M | Buy |
14,826
+675
| +5% | +$107K | 0.05% | 494 |
|
2024
Q1 | $1.83M | Buy |
14,151
+736
| +5% | +$95.3K | 0.04% | 576 |
|
2023
Q4 | $1.29M | Sell |
13,415
-9,289
| -41% | -$896K | 0.03% | 655 |
|
2023
Q3 | $2.75M | Buy |
22,704
+1,335
| +6% | +$162K | 0.06% | 397 |
|
2023
Q2 | $2.45M | Buy |
21,369
+3,910
| +22% | +$448K | 0.05% | 449 |
|
2023
Q1 | $2.41M | Buy |
17,459
+675
| +4% | +$93K | 0.05% | 463 |
|
2022
Q4 | $2.17M | Buy |
16,784
+65
| +0.4% | +$8.42K | 0.04% | 476 |
|
2022
Q3 | $1.85M | Buy |
16,719
+5,998
| +56% | +$663K | 0.04% | 524 |
|
2022
Q2 | $804K | Sell |
10,721
-10,764
| -50% | -$807K | 0.02% | 815 |
|
2022
Q1 | $1.68M | Sell |
21,485
-2,295
| -10% | -$179K | 0.03% | 637 |
|
2021
Q4 | $2.14M | Buy |
23,780
+229
| +1% | +$20.6K | 0.03% | 583 |
|
2021
Q3 | $2.18M | Sell |
23,551
-191
| -0.8% | -$17.7K | 0.03% | 566 |
|
2021
Q2 | $1.85M | Buy |
23,742
+3,296
| +16% | +$256K | 0.03% | 620 |
|
2021
Q1 | $1.52M | Buy |
20,446
+6,771
| +50% | +$505K | 0.02% | 684 |
|
2020
Q4 | $2.33M | Buy |
13,675
+5,133
| +60% | +$875K | 0.04% | 489 |
|
2020
Q3 | $1.2M | Buy |
8,542
+3,672
| +75% | +$516K | 0.02% | 653 |
|
2020
Q2 | $781K | Buy |
4,870
+3,481
| +251% | +$558K | 0.02% | 758 |
|
2020
Q1 | $136K | Sell |
1,389
-526
| -27% | -$51.5K | ﹤0.01% | 1177 |
|
2019
Q4 | $247K | Sell |
1,915
-1,960
| -51% | -$253K | ﹤0.01% | 1151 |
|
2019
Q3 | $292K | Buy |
3,875
+50
| +1% | +$3.77K | 0.01% | 1100 |
|
2019
Q2 | $581K | Buy |
3,825
+14
| +0.4% | +$2.13K | 0.01% | 961 |
|
2019
Q1 | $454K | Buy |
3,811
+338
| +10% | +$40.3K | 0.01% | 1101 |
|
2018
Q4 | $379K | Buy |
3,473
+470
| +16% | +$51.3K | 0.01% | 1047 |
|
2018
Q3 | $485K | Buy |
+3,003
| New | +$485K | 0.01% | 1066 |
|